AnaptysBio reports Q1 FY2027 results, Jemperli nears $1 billion in nine-month salesNov 12Regulatory decisionAnaptysBio, Inc.dostarlimab-gxlyUpdated
Phase II NEO-MEL-T melanoma trial posts results after reaching primary completionOct 20Trial updatecobolimabdostarlimab-gxly
FDA grants accelerated approval to dostarlimab for rectal cancerOct 19Regulatory decisiondostarlimab-gxlyGlaxoSmithKline
GSK registers large new Shingrix cardiovascular trial; DESTINY HES study update postedOct 15Weekly roundup, 4 itemsdepemokimabdostarlimab-gxly
GSK discloses FDA hold on infant pneumococcal vaccine study; posts two Phase 3/4 resultsOct 9Weekly roundup, 9 itemsdostarlimab-gxlyGlaxoSmithKlineUpdated
New Phase Ib myeloma study registered; GSK-linked FTD trial terminated, BRCA study postedSep 24Weekly roundup, 3 itemsAL001Alector, Inc.
GSK-linked trials: six new registrations this week, all not yet recruitingAug 6Weekly roundup, 6 itemsaletekitugbelantamab
GSK posts bepirovirsen QT results; registers Mo-Rez ovarian, endometrial Phase 3 trialsJul 10Weekly roundup, 6 itemsbepirovirsencamlipixant
GSK's DREAMM 12 posts results with 36 enrolled; COSTAR Lung stays active, not recruitingJul 1Weekly roundup, 2 itemsbelantamabbelantamab mafodotin